| Document |
Document Title |
|
WO/2020/034946A1 |
Provided is a method for preparing a cyclohexane derivative, the method comprising the following steps: subjecting a compound, 2-(4-(3,3-dimethylureido)cyclohexyl)acetaldehyde, represented by formula SM01 and a compound represented by fo...
|
|
WO/2020/036069A1 |
Provided are: a composition for forming a hole transporting layer for perovskite solar cells, which is inexpensive and does not need to be used together with a dopant; and a compound which can be contained in a composition for forming a ...
|
|
WO/2020/037251A1 |
This invention is a benzothiophene estrogen receptor modulator or its pharmaceutically acceptable salt, N-oxide, isotopic derivative or prodrug thereof or a pharmaceutically acceptable composition thereof to treat an estrogen-related med...
|
|
WO/2020/033782A1 |
The present invention is directed to compounds of Formula (I), which are activators of the RIG-I pathway.
|
|
WO/2020/027150A1 |
A compound represented by general formula (I) (wherein each symbol is as defined in the description) or a salt thereof has a potent neural protecting and/or repairing effect and, therefore, is usable as a therapeutic agent for neurologic...
|
|
WO/2020/022779A1 |
The present invention provides a novel heterocyclic compound and an organic light-emitting device using same.
|
|
WO/2020/021021A1 |
The present invention relates to ortho substituted phenoxypropylamino and benzyloxypropylamino derivatives having pharmacological activity towards the α2δ subunit of the voltage-gated calcium channel, in particular to ortho substituted...
|
|
WO/2020/012403A1 |
The present invention relates to an improved process for diastereoselective synthesis of vicinal diamines (1). The process involves highly regio- and diastereoselective addition of 2-azaallyl anions (4) to N-tert-butanesulfinylimines (5)...
|
|
WO/2020/013572A1 |
The present specification provides a compound of chemical formula 1 and an organic light emitting diode comprising same.
|
|
WO/2020/013574A1 |
The present specification provides a compound of chemical formula 1 and an organic light emitting diode comprising same.
|
|
WO/2020/011935A1 |
The invention relates to a new alkinylating and cyanating agent of the formula (I) or (II), and to the preparation and use thereof, for introducing nitrile(cyan) groups or alkyne groups into chemical target molecules by way of electrophi...
|
|
WO/2020/007905A1 |
The present disclosure relates to thienyloxazolones and analogues thereof of formula (III) that may be used for protecting plants from bacterial diseases, in particular from bacterial diseases caused by bacteria belonging to the genus Xa...
|
|
WO/2020/009554A1 |
The present invention provides a novel compound and an organic light-emitting device using same.
|
|
WO/2020/008052A1 |
The present invention relates to a compound of the following formula (I): (I). The invention also relates to uses thereof as dye or pigment, notably as a luster pigment. The invention relates also to a reflective or photonic or nanophoto...
|
|
WO/2020/009381A1 |
The present invention relates to a novel organic compound and an organic electroluminescent device using same and, more particularly, to a novel compound having excellent light-emitting ability and an organic electroluminescent device ha...
|
|
WO/2020/007902A1 |
The present disclosure relates to substituted thiophene carboxamides and analogues thereof of formula (I) that may be used for protecting plants from bacterial diseases, in particular from bacterial diseases caused by bacteria belonging ...
|
|
WO/2020/007904A1 |
The present disclosure relates to substituted thiophene carboxamides and analogues thereof of formula (II) that may be used for protecting plants from bacterial diseases, in particular from bacterial diseases caused by bacteria belonging...
|
|
WO/2020/002238A1 |
The present invention provides compounds of formula (I) for use in the treatment of respiratory diseases of animals, especially Bovine or Swine Respiratory disease (BRD and SRD).
|
|
WO/2020/002472A1 |
The present invention relates to novel nitrification inhibitors of formula (I), which are alkynylthiophene compounds. Moreover, the invention relates to the use of compounds of formula I as nitrification inhibitors, i.e. for reducing nit...
|
|
WO/2020/006177A1 |
Disclosed herein are small molecule Vascular Adhesion Protein- 1 (VAP-1) modulator compositions, pharmaceutical compositions, the use and preparation thereof.
|
|
WO/2020/004502A1 |
The present invention addresses the problem of providing a new method for synthesizing a fluorovinyl ether compound from a fluorine-containing vinyl compound, etc. To solve this problem, provided is a method for producing a compound repr...
|
|
WO/2019/243550A1 |
Thiophene derivatives of formula (I) and a pharmaceutically acceptable salt thereof are provided. These compounds have utility for the treatment or prevention of disorders caused by IgE, such as allergy, type 1 hypersensitivity or famili...
|
|
WO/2019/240532A1 |
The present specification relates to a heterocyclic compound of chemical formula 1 and an organic light-emitting device including same.
|
|
WO/2019/236562A1 |
The synthesis and application of a compound having unique and desired fragrance characteristics is provided herein. The compound of the present disclosure can be employed alone or incorporated as a fragrance component in fragrance compos...
|
|
WO/2019/231290A1 |
The present invention relates to a compound represented by chemical formula 1, or a pharmaceutically acceptable salt thereof. The compound according to the present invention is effectively useful for the prevention or treatment of autoph...
|
|
WO/2019/231272A1 |
The present specification provides a compound represented by chemical formula 1 and an organic light emitting device comprising same.
|
|
WO/2019/230864A1 |
The purpose of the present invention is to provide a method for manufacturing, inexpensively, efficiently, and on an industrial scale, a compound useful as an intermediate for synthesizing a pharmaceutical ingredient for an anti-diabetic...
|
|
WO/2019/232384A1 |
Compounds that may selectively inhibit Oplophorus luciferase-derived bioluminescent complexes, e.g., NanoBiT® bioluminescent complex, are disclosed as well as compositions and kits comprising the compounds, and methods of using the comp...
|
|
WO/2019/229464A1 |
There are described compounds of formula (I): (I) and their use as a medicament in the treatment of diseases associated with the abnormal or elevated catabolism of tryptophan, such as, cancer, immunosuppression, viral infection, depressi...
|
|
WO/2019/229239A1 |
A compound of formula (I) wherein: M is selected from Mo or W; X is selected from O or NR5; R1 and R2 are independently selected from H, C1-6 alkyl, and aryl; C1-6 alkyl and aryl optionally being substituted with one or more of C1-6 alky...
|
|
WO/2019/219820A1 |
A compound of formula (I), wherein: R1 is selected from (i) H, (ii) C3-6cycloalkyl, (iii) C3-7heterocyclyl optionally substituted with a group selected from: methyl and ester, and (iv) linear or branched C1-4alkyl optionally substituted ...
|
|
WO/2019/218418A1 |
Provided in the invention is a preparation method for synthesizing a photosensitive compound through a Claisen-Schmidt reaction. An aldehyde free of alpha-H and a ketone containing alpha-H are selected to be synthesized to obtain the pro...
|
|
WO/2019/219731A1 |
Compounds of the formula (I) in which R1, R2, R3, R4 and n have the meanings indicated in Claim 1, are inhibitors of HIF-2α, and can be employed for the treatment of diseases such as cancer.
|
|
WO/2019/216600A1 |
The present invention relates to an oxime ester group-substituted aromatic compound, a preparation method therefor, and a photoresist composition comprising same and is useful for providing a photosensitive composition, which effectively...
|
|
WO/2019/216415A1 |
The present disclosure addresses the problem of providing a production method for a novel fluoromethyl derivative. The problem is solved by a production method that is for a fluorinated organic compound represented by formula (1) [in the...
|
|
WO/2019/211568A1 |
The subject of the invention is a process for the synthesis of fluorinated aromatic molecules of formula (I) Ar2-A-B (I) in which Ar2 represents a (hetero)aryl; A represents an atom from the 16th group of the periodic table; B represents...
|
|
WO/2019/199911A1 |
In one aspect, the present disclosure provides a compound of the formula: In another aspect, the present disclosure also provides methods of preparing the compounds disclosed herein. In another aspect, the present disclosure also provide...
|
|
WO/2019/199939A1 |
In one aspect, the present disclosure provides a compound of the formula: (I) wherein the variables are as defined herein. In another aspect, the present disclosure also provides pharmaceutical compositions and methods of use of the comp...
|
|
WO/2019/194616A1 |
The present application relates to a compound of chemical formula 1 and an organic light emitting diode comprising same.
|
|
WO/2019/195063A1 |
Compounds of general formula (I), and their pharmaceutically acceptable salts, wherein R1, R2, R3, R5, R6, R8, R9, A, X1, X2, and X3 are defined herein, that may be useful as inductors of type I interferon production, specifically as STI...
|
|
WO/2019/193068A1 |
The present invention relates to a process for the synthesis of a carbon labeled organic compound containing a carbon labeled carboxyl group. The present invention also concerns the use of carbon labeled organic compounds containing a ca...
|
|
WO/2019/193159A1 |
The present invention relates to bumetanide derivatives of formula (I) as well as pharmaceutical compositions comprising these compounds for use in the treatment or prevention of diseases/disorders involving Na+- K+- 2CI- - cotransporter...
|
|
WO/2019/192395A1 |
The application relates to a strongly-polarized molecule of the following general formula: wherein A denotes a group having a polarizability greater than 2 C·m2/V; R1 and R2 are respectively hydrogen, halogen, a hydroxyl group, an amino...
|
|
WO/2019/195124A1 |
Compounds of general formula (I), of general formula (II), of general formula (III), of general formula (IV), of general formula (V), of general formula (VI), and their pharmaceutically acceptable salts, wherein all variables are defined...
|
|
WO/2019/185413A1 |
The present invention relates to cyclopropyl compounds of formula I, wherein the variables have the meanings as defined in the specification, to compositions comprising them, to active compound combinations comprising them, and to their ...
|
|
WO/2019/190272A1 |
The present application relates to a novel compound and an organic light-emitting device comprising same, the novel compound according to one embodiment of the present invention being applied to an organic light-emitting device to allow ...
|
|
WO/2019/190271A1 |
The present application relates to a novel compound and an organic light-emitting device comprising same, the novel compound according to one embodiment of the present invention being applied to an organic light-emitting device to allow ...
|
|
WO/2019/190270A1 |
The present application relates to a novel compound and an organic light-emitting device comprising same, the novel compound according to one embodiment of the present invention being applied to an organic light-emitting device to allow ...
|
|
WO/2019/190230A1 |
The present specification provides a compound represented by chemical formula 1 and an organic light emitting diode comprising same.
|
|
WO/2019/180627A1 |
The present invention relates to an improved asymmetric synthesis of alpha- (diarylmethyl) alkyl amines (hereafter referred to as the compound (1)) or its pharmaceutically acceptable salt and derivatives. The process comprises an unusual...
|
